41.95
price down icon1.55%   -0.66
after-market Dopo l'orario di chiusura: 41.95
loading

Celldex Therapeutics Inc Azioni (CLDX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
0.121
- 0.73 0.695 1.175
Operating Expenses
18.28%
87.07
73.62 64.59 63.43 57.00
Benefits Costs and Expenses
20.31%
58.66
73.62 64.59 63.43 19.99
Costs And Expenses
18.55%
87.27
73.62 64.59 63.43 57.20
Operating Income/Loss
18.39%
-87.15
-73.62 -63.86 -62.74 -56.03
Income/Loss From Continuing Operations Before Tax
20.48%
-58.54
-73.62 -56.60 -53.80 -18.81
Income/Loss From Continuing Operations After Tax
21.29%
-81.32
-67.04 -56.60 -53.80 -7.271
Net Income/Loss
21.29%
-81.32
-67.04 -56.60 -53.80 -47.09
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99,803%
66.36
0.0664 0.0664 0.0664 0.000658
Diluted Average Shares
99,803%
66.36
0.0664 0.0664 0.0664 0.000658
Basic Earnings Per Share
21.78%
-1.23
-1.01 -0.85 -0.81 -0.71
Diluted Earnings Per Share
21.78%
-1.23
-1.01 -0.85 -0.81 -0.71
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$63.32
price down icon 0.52%
$58.60
price up icon 0.07%
$36.20
price down icon 0.22%
$123.74
price down icon 2.05%
$228.65
price up icon 0.67%
ONC ONC
$347.48
price down icon 2.40%
Capitalizzazione:     |  Volume (24 ore):